NO154052C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.

Info

Publication number
NO154052C
NO154052C NO813263A NO813263A NO154052C NO 154052 C NO154052 C NO 154052C NO 813263 A NO813263 A NO 813263A NO 813263 A NO813263 A NO 813263A NO 154052 C NO154052 C NO 154052C
Authority
NO
Norway
Prior art keywords
quinolon
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO813263A
Other languages
English (en)
Norwegian (no)
Other versions
NO813263L (no
NO154052B (no
Inventor
Roy Victor Davies
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO813263L publication Critical patent/NO813263L/no
Publication of NO154052B publication Critical patent/NO154052B/no
Publication of NO154052C publication Critical patent/NO154052C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
NO813263A 1980-09-26 1981-09-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater. NO154052C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8031106 1980-09-26
GB8031162 1980-09-26
GB8119062 1981-06-19
GB8118879 1981-06-19

Publications (3)

Publication Number Publication Date
NO813263L NO813263L (no) 1982-03-29
NO154052B NO154052B (no) 1986-04-01
NO154052C true NO154052C (no) 1986-07-16

Family

ID=27449208

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813263A NO154052C (no) 1980-09-26 1981-09-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.

Country Status (25)

Country Link
US (2) US4442109A (el)
AT (1) AT379388B (el)
AU (1) AU549078B2 (el)
BG (2) BG36344A3 (el)
CA (1) CA1146943A (el)
CH (1) CH650254A5 (el)
DD (1) DD201890A5 (el)
DE (1) DE3138121A1 (el)
DK (1) DK152674C (el)
ES (2) ES505786A0 (el)
FI (1) FI812997L (el)
FR (1) FR2491064A1 (el)
GR (1) GR75797B (el)
IE (1) IE51542B1 (el)
IL (1) IL63845A (el)
IT (1) IT1189449B (el)
LU (1) LU83649A1 (el)
NL (1) NL8104394A (el)
NO (1) NO154052C (el)
NZ (1) NZ198414A (el)
PH (1) PH18605A (el)
PT (1) PT73666B (el)
RO (2) RO85318B (el)
SE (1) SE457533B (el)
YU (2) YU230181A (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (en) * 1984-01-13 1990-06-27 The Boots Company PLC Use of quinolones for the manufacture of a composition for the treatment of heart failure.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121725A (en) * 1960-07-18 1964-02-18 Phillips Petroleum Co N-heterocyclic sulfides, sulfoxides, sulfones, and n-oxides of said sulfoxides and sulfones
US3801644A (en) * 1971-08-25 1974-04-02 Warner Lambert Co Substituted-o-hydroxy-omega-(methylsulfinyl)acetophenones and process for producing same
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4302360A (en) * 1980-01-11 1981-11-24 Agency Of Industrial Science & Technology Catalyst for catalytic combustion of hydrogen

Also Published As

Publication number Publication date
CH650254A5 (fr) 1985-07-15
IL63845A (en) 1985-02-28
LU83649A1 (fr) 1983-02-22
ES8302662A1 (es) 1982-12-01
NO813263L (no) 1982-03-29
NO154052B (no) 1986-04-01
FR2491064B1 (el) 1984-03-16
US4447435A (en) 1984-05-08
FI812997L (fi) 1982-03-27
IT1189449B (it) 1988-02-04
AT379388B (de) 1985-12-27
DK152674C (da) 1988-08-22
DK152674B (da) 1988-04-11
BG36344A3 (en) 1984-10-15
FR2491064A1 (fr) 1982-04-02
DD201890A5 (de) 1983-08-17
IT8149370A0 (it) 1981-09-25
RO85318A (ro) 1984-09-29
AU7552481A (en) 1982-04-01
CA1146943A (en) 1983-05-24
GR75797B (el) 1984-08-02
ES514411A0 (es) 1983-05-01
US4442109A (en) 1984-04-10
IE51542B1 (en) 1987-01-07
ATA412181A (de) 1985-05-15
IE812033L (en) 1982-03-02
NZ198414A (en) 1983-11-18
YU230181A (en) 1983-12-31
YU144683A (en) 1983-12-31
RO82014A (ro) 1983-06-01
SE8105689L (sv) 1982-03-27
RO85318B (ro) 1984-10-30
DK424781A (da) 1982-03-27
IL63845A0 (en) 1981-12-31
BG36495A3 (en) 1984-11-15
DE3138121A1 (de) 1982-04-15
RO82014B (ro) 1983-05-30
ES505786A0 (es) 1982-12-01
PT73666B (en) 1982-11-22
NL8104394A (nl) 1982-04-16
SE457533B (sv) 1989-01-09
PT73666A (en) 1981-10-01
AU549078B2 (en) 1986-01-16
ES8306111A1 (es) 1983-05-01
PH18605A (en) 1985-08-21

Similar Documents

Publication Publication Date Title
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO161117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO155840C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO813821L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.